Prognostic Factors in Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib: A Retrospective Comparison with Previously Known Prognostic Models-Reference-Cited by-同舟云学术

Prognostic Factors in Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib: A Retrospective Comparison with Previously Known Prognostic Models

Published:2011 Issue:3-4 Volume:80 Page:167-174
ISSN:1423-0232
Container-title:Oncology
language:en
Short-container-title:Oncology

Author:

Baek Kyung Kee,Kim Jung-Hoon,Uhm Ji Eun,Park Se Hoon,Lee Jeeyun,Park Joon Oh,Park Young Suk,Kang Won Ki,Lim Ho Yeong

Publisher

S. Karger AG

Subject

Cancer Research,Oncology,General Medicine

Reference16 articles.

1. Annual Report of the Korea Central Cancer Registry Program 2000: Based on Registered Data from 131 Hospitals

2. Treatment of hepatocellular carcinoma: A systematic review of randomized controlled trials

3. Systemic therapy for advanced hepatocellular carcinoma: a review

4. BAY 43-9006 Exhibits Broad Spectrum Oral Antitumor Activity and Targets the RAF/MEK/ERK Pathway and Receptor Tyrosine Kinases Involved in Tumor Progression and Angiogenesis

5. Phase I Clinical and Pharmacokinetic Study of the Novel Raf Kinase and Vascular Endothelial Growth Factor Receptor Inhibitor BAY 43-9006 in Patients With Advanced Refractory Solid Tumors

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic Significance of Serum Albumin Level and Albumin-Based Mono- and Combination Biomarkers in Patients with Hepatocellular Carcinoma;Cancers;2023-02-04

2. The Latest Research Progress of Hepatic Arterial Infusion Chemotherapy versus Hepatic Arterial Chemoembolization in the Treatment of Hepatocellular Carcinoma;Advances in Clinical Medicine;2023

3. Assessment of circulating levels of microRNA-326, microRNA-424, and microRNA-511 as biomarkers for hepatocellular carcinoma in Egyptians;World Journal of Hepatology;2022-08-27

4. Prognostic models for outcome prediction in patients with advanced hepatocellular carcinoma treated by systemic therapy: a systematic review and critical appraisal;BMC Cancer;2022-07-09

5. A Nomogram-Based Prognostic Model for Advanced Hepatocellular Carcinoma Patients Treated with Sorafenib: A Multicenter Study;Cancers;2021-05-29